Overview

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

Status:
Completed
Trial end date:
2018-09-10
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled multi-center phase IIA study to evaluate the clinical efficacy and safety of Fugan ointment versus placebo applied to involved skin of subjects with mild to moderate subacute eczema.
Phase:
Phase 2
Details
Lead Sponsor:
Zai Lab Pty. Ltd.